ROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) (CIK 0001281895) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001140361-26-008290
- Form
- CORRESP
- Filer
- ROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) (CIK 0001281895)
- CIK
- 0001281895
- Ticker
- RCKT, RCKTW
- Filed
- 2026-03-06
- SIC industry
- 2834
- HQ
- New York, NY
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1281895/000114036126008290/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer